Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan
<p>Ember offers Japanese market pharmaceutical transportation solution integrating temperature control, visualization of transportation status and traceability LOS ANGELES, July 29, 2026 /PRNewswire/ -- Ember LifeSciences, Inc. ("Ember"), an award-winning provider of advanced pharmaceutical...</p>
Read original article ↗